Enfermedades inflamatorias y neoplásicas del tracto gastrointestinal, enfermedades hepáticas prevalentes
ENGASTRO
Universidad de Sevilla
Sevilla, EspañaPublications in collaboration with researchers from Universidad de Sevilla (4)
2024
-
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
Alimentary Pharmacology and Therapeutics
2023
-
Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction
Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 150-162
2022
-
Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes
Gut, Vol. 71, Núm. 10, pp. 2138-2140